echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Active Ingredient News > Digestive System Information > IBD: Risk of venous thromboembolism after discharge from hospital in patients with inflammatory bowel disease.

    IBD: Risk of venous thromboembolism after discharge from hospital in patients with inflammatory bowel disease.

    • Last Update: 2020-10-30
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    BACKGROUND: Inflammatory bowel disease (IBD) is associated with a high risk of venous thromboembolism (VTE) during hospitalization.
    it was not clear whether the link still existed after discharge.
    we aim to assess the rate of VTE after discharge from IBD patients and determine whether IBD is associated with increased VTE risk.
    : The researchers conducted a population-based queue study between 2002 and 2016.
    IBD adults who were hospitalized (≥72 hours) were divided into non-surgical and surgical queues and matched non-IBD controls on the tendency score.
    the time of VTE after discharge is assessed by the Kaplan-Meier method, and the VTE risk is evaluated through the Cox proportional risk model.
    : A total of 81,900 IBD discharged patients (62,848 non-surgical and 19,052 surgical) were matched with non-IBD controlled patients.
    of VTE was 2.3% in patients with non-surgical IBD 12 months after discharge, compared with 1.6% in surgical IBD patients.
    incidence of non-surgical IBD queues increased by 4% per year (OR, 1.04; 95% CI, 1.02-1.05).
    in our trend score matching analysis, non-surgical IBD patients ([HR,1.72; 95% CI, 1.51-1.96) and surgical patients with ulcerative colitis (HR, 1.68; 95% CI, 1.16-2.45) had a higher risk of developing VTE one month after discharge.
    : Non-surgical IBD patients and patients with ulcerative colitis surgery were 1.7 times more likely to have VTE after discharge than non-IBD patients.
    these findings support vigilance in the population and the need to consider the prevention of blood clots.
    .
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.